[1]
A. . Ozdemir, “The effects of glycemic control on malondialdehyde modified low-density-lipoprotein-immunglobulin G levels in type 2 diabetics”, Med Sci Discov, vol. 3, no. 2, pp. 76–80, Feb. 2016.